Patents by Inventor John Vest

John Vest has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS
    Publication number: 20240218369
    Abstract: Disclosed herein are methods for treating hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in a human patient in need thereof by administering an effective amount of a transthyretin (TTR)-inhibiting composition.
    Type: Application
    Filed: October 30, 2023
    Publication date: July 4, 2024
    Inventor: John Vest
  • METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TRANSTHYRETIN (TTR) iRNA COMPOSITIONS
    Publication number: 20240100080
    Abstract: The present invention provides methods for treating or preventing TTR-associated diseases using RNAi agents, e.g., double stranded RNAi agents, that target the transthyretin (TTR) gene.
    Type: Application
    Filed: April 12, 2023
    Publication date: March 28, 2024
    Inventors: Amy Chan, John Vest, Gabriel Robbie, Husain Z. Attarwala, Varun Goel
  • METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TRANSTHYRETIN (TTR) iRNA COMPOSITIONS
    Publication number: 20190350962
    Abstract: The present invention provides methods for treating or preventing TTR-associated diseases using RNAi agents, e.g., double stranded RNAi agents, that target the transthyretin (TTR) gene.
    Type: Application
    Filed: December 15, 2017
    Publication date: November 21, 2019
    Inventors: Amy Chan, John Vest, Gabriel Robbie, Husain Z. Attarwala, Varun Goel